Cargando…

Focusing on the Cell Type Specific Regulatory Actions of NLRX1

Cells utilize a diverse repertoire of cell surface and intracellular receptors to detect exogenous or endogenous danger signals and even the changes of their microenvironment. However, some cytosolic NOD-like receptors (NLR), including NLRX1, serve more functions than just being general pattern reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Fekete, Tünde, Bencze, Dóra, Bíró, Eduárd, Benkő, Szilvia, Pázmándi, Kitti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865811/
https://www.ncbi.nlm.nih.gov/pubmed/33525671
http://dx.doi.org/10.3390/ijms22031316
_version_ 1783647934526521344
author Fekete, Tünde
Bencze, Dóra
Bíró, Eduárd
Benkő, Szilvia
Pázmándi, Kitti
author_facet Fekete, Tünde
Bencze, Dóra
Bíró, Eduárd
Benkő, Szilvia
Pázmándi, Kitti
author_sort Fekete, Tünde
collection PubMed
description Cells utilize a diverse repertoire of cell surface and intracellular receptors to detect exogenous or endogenous danger signals and even the changes of their microenvironment. However, some cytosolic NOD-like receptors (NLR), including NLRX1, serve more functions than just being general pattern recognition receptors. The dynamic translocation between the cytosol and the mitochondria allows NLRX1 to interact with many molecules and thereby to control multiple cellular functions. As a regulatory NLR, NLRX1 fine-tunes inflammatory signaling cascades, regulates mitochondria-associated functions, and controls metabolism, autophagy and cell death. Nevertheless, literature data are inconsistent and often contradictory regarding its effects on individual cellular functions. One plausible explanation might be that the regulatory effects of NLRX1 are highly cell type specific and the features of NLRX1 mediated regulation might be determined by the unique functional activity or metabolic profile of the given cell type. Here we review the cell type specific actions of NLRX1 with a special focus on cells of the immune system. NLRX1 has already emerged as a potential therapeutic target in numerous immune-related diseases, thus we aim to highlight which regulatory properties of NLRX1 are manifested in disease-associated dominant immune cells that presumably offer promising therapeutic solutions to treat these disorders.
format Online
Article
Text
id pubmed-7865811
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78658112021-02-07 Focusing on the Cell Type Specific Regulatory Actions of NLRX1 Fekete, Tünde Bencze, Dóra Bíró, Eduárd Benkő, Szilvia Pázmándi, Kitti Int J Mol Sci Review Cells utilize a diverse repertoire of cell surface and intracellular receptors to detect exogenous or endogenous danger signals and even the changes of their microenvironment. However, some cytosolic NOD-like receptors (NLR), including NLRX1, serve more functions than just being general pattern recognition receptors. The dynamic translocation between the cytosol and the mitochondria allows NLRX1 to interact with many molecules and thereby to control multiple cellular functions. As a regulatory NLR, NLRX1 fine-tunes inflammatory signaling cascades, regulates mitochondria-associated functions, and controls metabolism, autophagy and cell death. Nevertheless, literature data are inconsistent and often contradictory regarding its effects on individual cellular functions. One plausible explanation might be that the regulatory effects of NLRX1 are highly cell type specific and the features of NLRX1 mediated regulation might be determined by the unique functional activity or metabolic profile of the given cell type. Here we review the cell type specific actions of NLRX1 with a special focus on cells of the immune system. NLRX1 has already emerged as a potential therapeutic target in numerous immune-related diseases, thus we aim to highlight which regulatory properties of NLRX1 are manifested in disease-associated dominant immune cells that presumably offer promising therapeutic solutions to treat these disorders. MDPI 2021-01-28 /pmc/articles/PMC7865811/ /pubmed/33525671 http://dx.doi.org/10.3390/ijms22031316 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fekete, Tünde
Bencze, Dóra
Bíró, Eduárd
Benkő, Szilvia
Pázmándi, Kitti
Focusing on the Cell Type Specific Regulatory Actions of NLRX1
title Focusing on the Cell Type Specific Regulatory Actions of NLRX1
title_full Focusing on the Cell Type Specific Regulatory Actions of NLRX1
title_fullStr Focusing on the Cell Type Specific Regulatory Actions of NLRX1
title_full_unstemmed Focusing on the Cell Type Specific Regulatory Actions of NLRX1
title_short Focusing on the Cell Type Specific Regulatory Actions of NLRX1
title_sort focusing on the cell type specific regulatory actions of nlrx1
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865811/
https://www.ncbi.nlm.nih.gov/pubmed/33525671
http://dx.doi.org/10.3390/ijms22031316
work_keys_str_mv AT feketetunde focusingonthecelltypespecificregulatoryactionsofnlrx1
AT benczedora focusingonthecelltypespecificregulatoryactionsofnlrx1
AT biroeduard focusingonthecelltypespecificregulatoryactionsofnlrx1
AT benkoszilvia focusingonthecelltypespecificregulatoryactionsofnlrx1
AT pazmandikitti focusingonthecelltypespecificregulatoryactionsofnlrx1